Form 4: West Pharmaceutical Services Director, William F. Feehery, Acquires Shares Through Restricted Stock Units

Director William F. Feehery acquired 1,071 shares of West Pharmaceutical Services common stock through restricted stock units, as reported in a recent SEC Form 4 filing.

Summary

• William F. Feehery, a director of West Pharmaceutical Services Inc., acquired 1,071 shares of common stock on May 6, 2025.
• The acquisition was through restricted stock units (RSUs).
• The shares were acquired at a price of $0.
• Following the transaction, Feehery directly owns 31,363.13 shares of West Pharmaceutical Services Inc.
• A Power of Attorney was executed on May 15, 2024, granting Luis Cantarero, Louis Lalli, Ryan Metz, and Caitlin Hippeli the authority to file Section 16(a) forms on Feehery's behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, but it's part of a standard compensation package, so it's not overwhelmingly positive.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder confidence.

Next Steps

• The acquired shares will vest at the next annual shareholder meeting.

Key Dates

Keywords

Form 4, West Pharmaceutical Services, Director, William F. Feehery, Beneficial Ownership, Restricted Stock Units, Section 16(a), Power of Attorney